top of page

Shortage of PARACETAMOL KABI paracetamol 1000mg/100mL

Dear Healthcare Professional,

 

Shortage of PARACETAMOL KABI paracetamol 1000mg/100mL solution for injection in freeflex bag (AUST R: 218687) and PARACETAMOL KABI paracetamol 1000mg/100mL solution for injection vial (AUST R: 203624) and alternate supply arrangement under Section 19A of the Therapeutic Goods Act 1989.

 

The above Australian registered medicines sponsored by Fresenius Kabi Australia Pty Ltd are currently in shortage due to manufacturing issues.

 

Pro Pharmaceuticals Group has arranged for the supply of an alternative product, PARACETAMOL S.A.L.F 10mg/mL (1000mg/100mL) solution for infusion bottle (Israel). This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 31st October 2024 


Please pass this onto your members.


We have attached the Dear Health Care Professional letter along with the Product Information and Pack Insert , please let us know if you have any questions.


For any orders please email to orders@propg.com.au or visit our website www.propg.com.au


ree

 
 
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

TEL:

1300 077 674 (1300 0 PRO PG)

FAX:

(03) 86790397

AUSTRALIA​      |  GERMANY  |      POLAND

Legal & Trademark Notice
© 2025 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page